Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 168

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 168
---
efinite            |     | Medical Council of Kyrgyzstan                                      |
|            |     |                                |     | Number &numero;0002953 Medical Practitioner           |     | 25 April 2018 - Indefinite            |     | Medical Council of Kyrgyzstan                                      |
|            |     |                                |     | Number &numero;11373\2565 Medical Certificate         |     | 16 August 2024 - Indefinite           |     | Medical Council of Kyrgyzstan                                      |
|            |     |                                |     | Number &numero;0003447 Medical Certificate            |     | 12 April 2023 - Indefinite            |     | Medical Council of Kyrgyzstan                                      |

<div align='center'>100</div>

Customers

For the years ended December 31,
2024 and 2023, the majority of NewGenIvf’s clients were from China (including mainland China and Hong Kong). The number of Thai
and Cambodian local patients generally increased in 2023 and 2024 compared with earlier years due to the impact of COVID-19 on international
travel. NewGenIvf enters into a service agreement with each of its customers that outline, among other things, the scope of services,
service fees, payment terms and rights, responsibilities and obligations of each party. Consent is obtained from the patients prior to
the provision of the various treatments. Customers are not entitled to enjoy the relevant services until outstanding amounts have been
settled pursuant to the relevant contract. Sales to individual consumers did not vary significantly and none of the customers contribute
more than 10% of NewGenIvf’s revenue for the years ended December 31, 2024 and 2023.

In addition to significant
customers using NewGenIvf’s IVF treatment services and surrogacy and ancillary caring services, NewGenIvf also has customers who
utilize the access to the freezing and storage facility and other relatively insignificant services, such as check-ups services, blood
test services and other minor services (the latter category of customers are referred to as “consultation customers”).

In addition to significant
customers using NewGenIvf’s IVF treatment services and surrogacy and ancillary caring services, NewGenIvf also has customers who
only use its relatively insignificant services, such as check-ups services, blood test services and other minor services (the latter category
of customers are referred to as “consultation customers”).

Sales and Marketing